HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Online-Only Appendix All Versions of this Article: db08-0393v1 57/11/3056    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Cozar-Castellano, I. Articles by Stewart, A. F. PubMed PubMed Citation Articles by Cozar-Castellano, I. Articles by Stewart, A. F. Social Bookmarking                What's this?

Lessons from the First Comprehensive Molecular Characterization of Cell Cycle Control in Rodent Insulinoma Cell Lines

From the ¹Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA; and
²Department of Pharmacology & Therapeutics, University of Florida, Gainesville, FL

Objective: Rodent insulinoma cell lines may serve as a model for designing continuously replicating human beta cell lines, and provide clues as to the central cell cycle regulatory molecules in the beta cell.

Research Design and Methods: We performed a comprehensive G1/S proteome analysis on the four most widely studied rodent insulinoma cell lines, and defined their flow cytometric profiles and growth characteristics.

Results: a) Despite their common T-Antigen-derived origins, MIN6 and BTC3 cells display markedly different G1/S expression profiles; b) despite their common radiation origins, RINm5F and INS1 cells display striking differences in cell cycle protein profiles; c) phosphorylation of pRb is absent in INS1 and RINm5F cells; d) cyclin D2 is absent in RINm5F and BTC3 cells, and therefore apparently dispensable for their proliferation; e) every cell cycle inhibitor is upregulated, presumably in a futile attempt to halt proliferation; f) among the G1/S proteome members, seven are pro-proliferation molecules: cdks-1, 2, 4, and 6, cyclins A, E and D3; and, g) overexpression of the combination of these seven converts arrested proliferation rates in primary rat beta cells to those in insulinoma cells. Unfortunately, this therapeutic overexpression appears to mildly attenuate beta cell differentiation and function.

Conclusions: These studies underscore the importance of characterizing the cell cycle at the protein level in rodent insulinoma cell lines. They also emphasize the hazards of interpreting data from rodent insulinoma cell lines as modeling normal cell cycle progression. Most importantly, they provide seven candidates targets for inducing proliferation in human beta cells.

Key Words: Insulinoma cell lines • beta cell proliferation • cell cycle • cdks and cyclins

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?